Next Generation Sequencing Market: By Product And Service Type (Pre-sequencing products and services market,( DNA fragmentation, size selection, A-tailing, and end repair, Library preparation and target enrichment, Quality control), Sequencing services market (Targeted sequencing/gene panels, RNA-Seq, De Novo sequencing, Exome sequencing, Chip-Seq, Whole-genome sequencing, Methyl-Seq, others ), Next-generationn Sequencing, Data Analysis, storage, and management (Bioinformatics) market (NGS data analysis software & workbenches, NGS data analysis services, NGS storage management and cloud computing solutions)), By Technology (Ion semiconductor sequencing, Sequencing by the synthesis (SBS), Nanopore sequencing, Single-molecule real-time (SMRT) sequencing), By Application (Drug discovery, Diagnostics, Agriculture and animal research, Biomarker discovery, Precision medicine, Other applications),BY End User (Biotechnology and Pharmaceutical Companies, Research Centres, Hospitals & Clinics, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Next generation sequencing market size was valued at 9.5 Billion in 2022 and is expected to grow at US$ 27.67 Billion at a CAGR of 16.5% from 2023 to 2029. Improvising costs related to NGS platforms and improving regulatory framework and reimbursement scenario for particular diagnosis tests related to NGS are the key drivers leading the market with low cost, high speed, and accuracy are main advantages. Lack of skilled professionals, and ethical and legal limitations are the resistance. New technology with include machine learning, predictive algorithms, and automation of global analytic libraries, data scientists anticipate multiple opportunities in the global next-generation sequencing market. Global next-generation sequencing market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes on the basis of product type, application, technology, end-user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and service providers engaged in global next generation sequencing market

 

Global Next Generation Sequencing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

18.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Next-Generation Sequencing Market Dynamics

Next generation sequencing market is driven by technological development in next-generation sequencing, an increase in the various applications, a decrease in the cost of sequencing, an increase in gene mapping programs, increasing automation for pre-sequencing programs, and the development of personalized medicine which are expected to fuel the next generation sequencing market. Moreover, the rise in R&D activities by the market players and drug discovery applications are driving the demand for next generation sequencing market. However, a lack of skilled professionals, ethical and legal issues in the interpretation, storage, and management of patient data, and high reliability on funding from the government might hamper the next generation sequencing market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Next Generation Sequencing Market Segmentation

By Product
  • Pre-sequencing products and services market
    • DNA fragmentation, size selection, A-tailing, and end repair
    • Library preparation and target enrichment
    • Quality control
  • Sequencing services market
    • Targeted sequencing/gene panels
    • RNA-Seq
    • De Novo sequencing
    • Exome sequencing
    • Chip-Seq
    • Whole-genome sequencing
    • Methyl-Seq
    • others
  • Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market
    • NGS data analysis software & workbenches
    • NGS data analysis services
    • NGS storage management and cloud computing solutions
By Technology
  • Ion semiconductor sequencing
  • Sequencing by the synthesis (SBS)
  • Nanopore sequencing
  • Single-molecule real-time (SMRT) sequencing
By Application
  • Drug discovery
  • Diagnostics
  • Agriculture and animal research
  • Biomarker discovery
  • Precision medicine
  • Other applications
By End-User
  • Biotechnology and Pharmaceutical Companies
  • Research Centres
  • Hospitals & Clinics
  • Others
By Geography
  • North America
  • Asia-pacific
  • Europe
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The major key players operating in the next generation sequencing market are: Illumina, Inc., BGI Group, PerkinElmer Inc., Macrogen, Hamilton Company, Lucigen, Intrexon Bioinformatics GmbH, Partek Incorporated, DNASTAR, Inc., DNAnexus, Hoffmann-La Roche Ltd., Becton Dickinson and Company, Danaher, Oxford Nanopore Technologies, Agilent Technologies, Inc.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Agilent Technologies,
  • Illumina,
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen N. V.
  • Beijing Genomics Institute
  • PerkinElmer,
  • F. Hoffmann La Roche AG
  • Genomatix GmbH
  • Oxford Nanopore Technologies
  • Eurofins Scientific

Adjacent Markets